Adiponectin is an anti-inflammatory protein whose levels are reduced in obesity, T2DM, insulin resistance, and MetS[70] and when reduced it has been associated with increased risk of diverse cancers[71-73]. This evidence concerns the gene ADIPOQ and metabolic syndrome.